Magnetar Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Magnetar Financial’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,173,294	Closed	-$72.2M	–	917
2022 Q4	$72.2M	Sell	2,173,294 -74,865	-3%	-$2.41M	1.22%	15
2022 Q3	$70.9M	Buy	+2,248,159	New	+$72.8M	0.98%	13
2018 Q4	–	Sell	-34,351	Closed	-$512K	–	545
2018 Q3	$512K	Buy	+34,351	New	+$533K	0.01%	197

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Magnetar Financial's VIVO Position: Q1 2023 in Review

Magnetar Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,173,294 shares — an estimated $72.2M sold.

Magnetar Financial first reported a position in VIVO in Q3 2018 and held it in 3 quarters. The position peaked at $72.2M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Magnetar Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Magnetar Financial sold 2,173,294 Meridian Bioscience Inc shares in Q1 2023, an estimated $72.2M.
Magnetar Financial first reported a position in Meridian Bioscience Inc in Q3 2018 and held it in 3 quarters.
Magnetar Financial's Meridian Bioscience Inc position peaked at $72.2M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.